Summary
GlobalData's Medical Devices sector report, “Peripherally Inserted Central Catheter (PICC) - Medical Devices Pipeline Assessment, 2016" provides an overview of Peripherally Inserted Central Catheter (PICC) currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripherally Inserted Central Catheter (PICC) pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Peripherally Inserted Central Catheter (PICC) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Peripherally Inserted Central Catheter (PICC) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Peripherally Inserted Central Catheter (PICC) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Companies Mentioned
AngioDynamics, Inc.
C. R. Bard, Inc.
NexGen Medical Systems, Inc.
University of Texas Health Science Center at Houston
'
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 Peripherally Inserted Central Catheter (PICC) Overview 4
3 Products under Development 5
3.1 Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Stage of Development 5
3.2 Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Territory 6
3.3 Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Regulatory Path 7
3.4 Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Estimated Approval Date 8
4 Peripherally Inserted Central Catheter (PICC) - Pipeline Products under Development by Companies 9
4.1 Peripherally Inserted Central Catheter (PICC) Companies - Pipeline Products by Stage of Development 9
4.2 Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Stage of Development 10
5 Peripherally Inserted Central Catheter (PICC) Companies and Product Overview 11
5.1 AngioDynamics, Inc. Company Overview 11
5.1.1 AngioDynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 11
5.2 C. R. Bard, Inc. Company Overview 14
5.2.1 C. R. Bard, Inc. Pipeline Products & Ongoing Clinical Trials Overview 14
5.3 NexGen Medical Systems, Inc. Company Overview 20
5.3.1 NexGen Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
5.4 University of Texas Health Science Center at Houston Company Overview 21
5.4.1 University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 21
6 Peripherally Inserted Central Catheter (PICC)- Recent Developments 23
6.1 May 11, 2016: Teleflex Prices Public Offering of 4.875% Notes Due 2026 for USD400 Million 23
6.2 May 10, 2016: ICU Medical Announces First Quarter 2016 Results 23
6.3 May 03, 2016: Cook Medical Issues Global, Voluntary Recall of Catheters with Beacon Tip Technology 24
6.4 Feb 03, 2016: ICU Medical Announces Fourth Quarter and Fiscal Year 2015 Results 25
6.5 Jan 11, 2016: Teleflex Highlights a Comparison of Eluting vs Non-Eluting Technologies on Peripherally Inserted Central Catheters (PICCs) in Preventing Thrombus Accumulation 26
6.6 Nov 05, 2015: ICU Medical Announces Third Quarter 2015 Results 26
6.7 Oct 28, 2015: Access Scientific's POWERWAND Midline IV Catheter Sets New Industry Standard for Power Injectabilty 27
6.8 Sep 30, 2015: Galt Medical and Health Line Launch Nexus CT Midline Catheter with MST Insertion Kit 27
6.9 Sep 30, 2015: Tangent Medical Technologies Raises USD1 Million in Financing 28
6.10 Sep 23, 2015: Teleflex to Showcase Arrow Endurance Extended Dwell Peripheral Catheter System at AVA 2015 Meeting in Dallas 28
6.11 Sep 23, 2015: B. Braun to Sponsor Platinum Showcase and Present at AVA 29
6.12 Aug 10, 2015: ICU Medical Announces Second Quarter 2015 Results 29
7 Appendix 31
7.1 Methodology 31
7.2 About GlobalData 33
7.3 Contact Us 34
7.4 Disclaimer 34
1.1 List of Tables
Table 1: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Stage of Development 5
Table 2: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Territory 6
Table 3: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Regulatory Path 7
Table 4: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Estimated Approval Date 8
Table 5: Peripherally Inserted Central Catheter (PICC) Companies - Pipeline Products by Stage of Development 9
Table 6: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Stage of Development 10
Table 7: AngioDynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 11
Table 8: BioFlo PICC Line Extension - Product Status 12
Table 9: BioFlo PICC Line Extension - Product Description 12
Table 10: Next Generation BioFlo PICC - Product Status 13
Table 11: Next Generation BioFlo PICC - Product Description 13
Table 12: C. R. Bard, Inc. Pipeline Products & Ongoing Clinical Trials Overview 14
Table 13: 3CG Port Placement System - Product Status 15
Table 14: 3CG Port Placement System - Product Description 15
Table 15: Antimicrobial PICC - Product Status 16
Table 16: Antimicrobial PICC - Product Description 16
Table 17: COVERT PowerPICC - Product Status 17
Table 18: COVERT PowerPICC - Product Description 17
Table 19: Internal Jugular Placement Catheter - Product Status 18
Table 20: Internal Jugular Placement Catheter - Product Description 18
Table 21: Thromboresistant PICC - New Version - Product Status 19
Table 22: Thromboresistant PICC - New Version - Product Description 19
Table 23: NexGen Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
Table 24: Channel Catheter - Product Status 20
Table 25: Channel Catheter - Product Description 20
Table 26: University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 21
Table 27: Automated Catheter Insertion System - Product Status 22
Table 28: Automated Catheter Insertion System - Product Description 22
Table 29: Glossary 32
1.2 List of Figures
Figure 1: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Stage of Development 5
Figure 2: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Territory 6
Figure 3: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Regulatory Path 7
Figure 4: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Estimated Approval Date 8
